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Summary
Cell growth is regulated by coordination of both extracellular nutrients and intracellular metabolite
concentrations. AMP activated kinase and mammalian target of rapamycin complex 1 serve as key
molecules that sense cellular energy and nutrients levels, respectively. In addition, the
dioxygenase family, including prolylhydroxylase, lysine demethylase, and DNA demethylase, has
emerged as possible sensors of intracellular metabolic status. The interplay among nutrients,
metabolites, gene expression, and protein modification are involved in the coordination of cell
growth with extracellular and intracellular conditions.
A fundamental issue in cell biology is how cells coordinate their growth with nutrient
availability. Cells have developed exquisite mechanisms to sense nutrient status and adjust
their behavior to maintain growth or cope with stress. Extensive studies have revealed that
the AMP activated kinase (AMPK) acts as a master energy sensor to modulate cellular
activities in response to energy stress, while the target of rapamycin (TOR) regulates cell
growth by monitoring levels of amino acids and growth stimulating signals. The
dioxygenase family, including prolylhydroxylase, lysine demethylase, and DNA
demethylase, has emerged as possible sensors of metabolic status to regulate gene
expression and cellular functions. Therefore, nutrients and metabolites actively participate in
cellular regulation through a variety of mechanisms.
Mechanisms of nutrient sensing
Energy sensing
Living cells use ATP as the most important direct energy source. Hydrolysis of ATP to ADP
and phosphate (or AMP and pyrophosphate) provides energy for most biological processes.
The ratio of ATP to ADP and AMP is a barometer of cellular energy status, and is therefore
tightly monitored by the cell. In eukaryotic cells, AMP-activated protein kinase (AMPK)
serves as a key cellular energy sensor and a master regulator of metabolism to maintain
energy homeostasis (Fig. 1) (Carling, 2004; Hardie, 2007). AMPK exists as heterotrimeric
complexes consisting of a catalytic α subunit and two regulatory subunits, β and γ. AMPK
senses energy levels by direct binding of AMP, ADP or ATP via the adenine nucleotide-
binding sites of the γ subunit. Binding of AMP or ADP leads to conformational change of
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the enzyme and activates AMPK through several mechanisms, including allosteric
activation, promoting the phosphorylation of the conserved threonine in the activation loop
of AMPK by upstream kinases while at the same time preventing its dephosphorylation of
the activation loop (Hardie, 2011). Among the three mechanisms, inhibiting
dephosphorylation of the activation loop is most crucial for AMPK activation by AMP or
ADP in vivo. AMP-promoted activation was considered for a long time as the key
mechanism of AMPK regulation. However, recent studies demonstrated that ADP, with a
similar affinity as AMP in binding the γ subunit, is also able to activate AMPK (Oakhill et
al., 2011; Xiao et al., 2011). Because intracellular concentrations of ADP are usually much
higher than AMP, ADP has emerged as a more relevant physiological activator of AMPK
under most stress. However, the AMP-specific ability of AMPK allosteric activation, which
can increase AMPK activity approximately 10 fold, makes AMP as an essential regulator
under severe energy stress. Thus, AMPK activity is capable of responding to the different
levels of energy demands responding appropriately.
Amino acid sensing
Amino acids, the building blocks of proteins, are also essential nutrients for cell growth.
Amino acids can also be used for the synthesis of nucleic acid, glucose, and ATP. In all
eukaryotes, the target of rapamycin (TOR), a conserved central cell growth modulator and
serine/threonine kinase, is tightly regulated by amino acid availability. Mammalian TOR
(mTOR) exists in two different complexes, mTORC1 and mTORC2, which are
distinguished by unique accessory proteins: Raptor and Rictor, respectively. Furthermore,
the two mTOR complexes are differentially regulated and only mTORC1 is sensitive to
amino acids (Fig. 1).
Extensive efforts have been taken to elucidate the mechanisms through which mTORC1
senses intracellular amino acids. The Rag GTPases have been shown to be key transducers
between amino acids and mTORC1 activation (Fig. 1) (Kim et al., 2008; Sancak et al.,
2008). The Rag proteins form heterodimers consisting of RagA or RagB bound to RagC or
RagD and are localized on lysosomes. Amino acids activate the heterodimers by promoting
GTP loading of RagA/B and GDP loading of RagC/D. The active Rag heterodimers
physically interact with mTORC1 through binding to Raptor, thereby recruiting mTORC1 to
the surface of lysosomes where it may interact with and be activated by the small GTPase
Rheb (Inoki et al., 2003a; Saucedo et al., 2003; Stocker et al., 2003). Rheb is regulated by
growth factor signals via the action of the TSC1/TSC2 tumor suppressor proteins. This
model explains why mTORC1 activation requires both growth factors and amino acids.
Recent studies have demonstrated that the Ragulator complex, which is associated with the
lysosome membrane, promotes nucleotide exchange and activation of Rag GTPases (Sancak
et al., 2010). The Ragulator complex functions as a guanine nucleotide exchange factor
(GEF) for RagA/B (Bar-Peled et al., 2012), although the precise mechanism remains to be
uncovered. Interestingly, VAM6 has been reported to function as a GEF for the yeast Rag
homologs (Binda et al., 2009); however, the question has been raised as to whether
mammalian VAM6 homolog has GEF activity towards Rag GTPases. Recent work further
demonstrated that the Ragulator complex is regulated by the lysosomal vacuolar H+-
adenosine triphosphatase (v-ATPase), which senses intra-lysosomal amino acid levels by an
unknown mechanism (Zoncu et al., 2011). These studies argue that amino acid signaling to
mTORC1 begins within the cell instead of at the plasma membrane, and the lysosome
appears to be a key player (Fig. 1). Besides the Ragulator complex, other proteins have been
implicated in the regulation of Rag GTPases, including leucyl-tRNA synthetase in both
yeast and mammals that may serve as intracellular leucine sensor (Bonfils et al., 2012; Han
et al., 2012), signaling adaptor protein p62 that promotes the formation of the active Rag
heterodimers (Duran et al., 2011) and SH3 domain-binding protein 4 (SH3BP4) that binds to
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the inactive Rag GTPase complex under nutrient stress and inhibits the formation of active
Rag complex (Kim et al., 2012).
GCN2 (general control non-derepressible-2) kinase functions as an amino acid sensor in
eukaryotic cells. Under amino acid deficiency, uncharged aminoacyl-tRNA accumulates and
binds to the aminoacyl-tRNA synthetase-like domain in GCN2. This leads to the activation
of GCN2 kinase (Hinnebusch, 2005). Activated GCN2 is able to phosphorylate eukaryotic
translation initiation factor 2-alpha (eIF2α) and reduces general translational initiation.
Additionally, activated GCN2 induces the translation of specific mRNAs, such as the
transcription factor ATF4, which promotes expression of stress responsive genes (Wek et
al., 2006). Therefore, activation of GCN2 and inhibition of mTORC1 similarly act to
suppress global protein synthesis in response to amino acid deficiency. GCN2 may also be
involved in the regulation of mTOR signaling; although, the mechanisms involved in this is
currently not clear (Novoa et al., 2001; Watanabe et al., 2007).
Oxygen sensing
Besides the conventional nutrients, such as amino acids and glucose, oxygen is also critical
for cell growth and cellular activity and can be considered as a nutrient. Prolyl hydroxylase
domain protein (PHD) carries out one of the best-characterized oxygen sensing mechanisms
in cellular regulation (Reviewed by Kaelin and Ratcliffe, 2008). PHD is a member of the
dioxygenase family that uses molecular oxygen and α-ketoglutarate (α-KG) to hydroxylate
conserved prolyl residues in hypoxia inducible factor α (HIFα), which is the activating
subunit of the HIF heterodimeric transcription factor (Fig. 2B). Hydroxylated HIFα is
recognized by the von Hippel-Lindau tumor suppressor protein pVHL, which is a substrate
recognition subunit of an E3 ubiquitin ligase. Recruitment of hydroxylated HIFα to the
pVHL-E3 ubiquitin ligase leads to its ubiquitination and a rapid clearance by the proteasome
system. During HIFα hydroxylation, molecular oxygen level is a key determinant in
controlling PHD activity (Nakayama et al., 2004). When oxygen levels are high, such as
during normoxic conditions, HIFα is rapidly hydroxylated and degraded resulting in low
HIFα protein levels under oxygen sufficient conditions. However, when oxygen levels are
low, referred to as hypoxia, the activity of PHD is inhibited due to the lack of this essential
co-factor in the hydroxylation reaction.
Under hypoxic conditions, HIFα stabilization and accumulation leads to the activation of a
transcriptional program preparing cells to adapt to the conditions. For example, HIFα
induces expression of glycolytic genes, allowing cells to use oxygen-independent glycolysis
instead of oxygen-dependent oxidative phosphorylation to produce energy to maintain
essential cellular activity (Gordan et al., 2007). In addition, HIFα activation also stimulates
expression of genes to promote blood vessel growth, thus increasing oxygen supply to
tissues experiencing hypoxia (Majmundar et al., 2010). Notably, HIF1α also inhibits
mTORC1 activity during hypoxia by inducing the expression of REDD1 (also known as
RTP801 or DDIT4) (Brugarolas et al., 2004; Corradetti et al., 2005; Sofer et al., 2005),
which represses mTORC1 by promoting the release of sequestered TSC2 from 14-3-3
proteins (DeYoung et al., 2008). Inhibition of mTORC1 by HIF1α may protect cells from
hypoxic stress by reducing ATP-consuming protein synthesis while increasing autophagy
(discussed in following paragraphs). Finally, the interplay between HIF1α and MYC, a key
transcriptional factor in cell growth, plays important roles in the regulation of cell growth
and metabolism during hypoxia (Reviewed by Dang et al., 2008; Gordan et al., 2007).
FIH (factor inhibiting HIF1) is a PHD domain containing dioxygenase and also participates
in oxygen sensing through regulation of the HIF transcription factor. FIH hydroxylates
HIFα on asparagine residues in an oxygen dependent manner (Hewitson et al., 2002; Lando
et al., 2002a). The asparagine hydroxylation does not promote HIFα degradation but rather
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inhibits the transcriptional activation activity of HIFα, possibly by interfering with co-
activators interactions, such as the histone acetyltransferase p300 (Lando et al., 2002b;
Mahon et al., 2001). Therefore, the adaptive transcriptional program activated by lack of
cellular oxygen is under multifaceted control by dioxygenases, directly linking oxygen
availability to HIF1α stability.
Regulation of metabolism by nutrient signaling
Nutrient sensors play an essential role in maintaining cellular homeostasis by regulating
downstream metabolic processes. For example, activation of AMPK strongly promotes
catabolic pathways to produce ATP while switching off ATP-consuming anabolic pathways.
In contrast, mTORC1 activation under nutrient-sufficient conditions leads to significant
elevation of anabolic processes, such as protein synthesis, to generate building materials
required for cell growth.
Glucose homeostasis
Activation of AMPK by increased energy demands promotes the utilization of glucose to
generate ATP through multiple modes of action (Fig. 1). First, AMPK up-regulates glucose
uptake by promoting the expression and function of glucose transporters (Hardie, 2011).
Second, AMPK promotes glycolysis under anaerobic conditions by phosphorylating and
activating 6-phosphofructo-2-kinase (PFK-2), the enzyme responsible for the synthesis of
glycolytic activator fructose 2,6-bisphosphate (Marsin et al., 2000). Third, AMPK promotes
mitochondrial biogenesis. Fourth, AMPK inhibits gluconeogenesis, an energy consuming
glucose synthetic pathway mainly found in the liver (Hardie, 2011). Finally, AMPK is able
to phosphorylate and inhibit glycogen synthase (GS) and thus reduce glycogen synthesis
(Carling and Hardie, 1989; Jorgensen et al., 2004). Therefore, AMPK modulate glucose and
glycogen metabolism through multiple mechanisms.
AMPK can also influence glucose homeostasis by inhibiting mTORC1. It has been well
established that activation of mTORC1 promotes glucose uptake and glycolytic flux by
increasing both transcription and translation of HIF1α (Duvel et al., 2010; Wouters and
Koritzinsky, 2008). However, there seems to be a dilemma that mTORC1 positively
regulates HIF1α while itself is inhibited by hypoxia. This may serve as a feedback
mechanism. Further studies are needed to elucidate the mechanisms and functional
implication of mTOR-dependent regulation of HIF1α. Interestingly, hyperactivation of
mTORC1 under nutrient-excess conditions has a negative feedback effect on glucose
catabolism. Prolonged activation of S6 kinase 1 (S6K1, a major downstream substrate of
mTORC1) caused by mTOR hyperactivation phosphorylates and dampens the insulin
receptor substrate (IRS1) (Harrington et al., 2004; Shah and Hunter, 2006; Tremblay et al.,
2007), leading to insulin desensitization and inhibition of Akt activity (Fig. 1). Consistently,
mice deficient for S6K1 showed elevated insulin sensitivity when fed on high fat diet (Um et
al., 2004). In addition, phosphorylation of Grb10 by mTORC1 may also suppress signaling
of insulin and other receptor tyrosine kinases (Hsu et al., 2011; Yu et al., 2011). This
feedback loop reduces glucose uptake and glycogen synthesis, and increases
gluconeogenesis as results of mTORC1 hyperactivation.
Recent studies have revealed new roles of mTORC1 in intracellular energy control.
Inhibition of the hyperactivated mTORC1 in TSC1/2 mutant cells is sufficient to protect cell
death from glucose deprivation (Choo et al., 2010). Notably, deprivation of both glucose and
glutamine, two major carbon sources feeding mitochondrial (tricarboxylic acid) TCA cycle,
inhibits mTORC1 activity in a manner independent of AMPK, TSC1/2 or Rag GTPases
(Kim et al., 2013). Instead, energetic stress induced by glucose and glutamine starvation
inhibits mTORC1 signaling through repressing Tel2-Tti1-Tti2-RUVBL1/2 complex, an
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AAA+ ATPase-containing complex. Consistently, ATP depletion by mitochondrial
inhibition significantly blocks mTORC1 activation and lysosomal localization, which is also
independent of AMPK or Rag GTPases (Kim et al., 2013). These studies suggest another
potential mechanism of mTORC1 regulation by cellular energy status.
Protein synthesis and autophagy
Protein synthesis is the best-characterized process regulated by mTORC1. mTORC1 plays a
key role in translational control by phosphorylating a myriad of translation regulators,
including eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) and
S6K1 (Ma and Blenis, 2009). Inhibition of the 4E-BP family of translation repressor plays a
major role in the translation activation by mTOR (Fig. 1) (Thoreen et al., 2012). The role of
mTOR in translational regulation has been extensively reviewed (Ma and Blenis, 2009) and
will not be discussed in detail here. Notably, since protein synthesis consumes a large
portion of cellular energy, AMPK activation induced by energy stress significantly inhibits
protein synthesis, resulting in the AMPK-mTORC1 crosstalk (Fig. 1). AMPK attenuates
mTORC1 signaling through phosphorylation and activation of tuberous sclerosis 2 (TSC2)
(Inoki et al., 2003b), a negative regulator of mTORC1. AMPK also directly phosphorylates
Raptor, which induces 14-3-3 binding to raptor and repression of mTORC1 activity (Gwinn
et al., 2008). Besides the indirect effect through mTORC1, AMPK inhibits translation by
inhibiting the eukaryotic elongation factor-2 (eEF2) kinase, which phosphorylates and
inhibits eEF2 (Browne et al., 2004; Horman et al., 2002).
Under severe energy or nutrient stress conditions, a mere inhibition of biosynthesis is not
sufficient and cells have to find strategies to cope with resource shortage for survival.
Autophagy is a critical process for cell survival under stress conditions. It enables the
recycling of non-essential macromolecules and organelles to provide nutrients and energy to
maintain essential activity and biosynthesis of pivotal components (He and Klionsky, 2009;
Mizushima and Komatsu, 2011). Autophagy is strongly induced during nutrient deprivation.
Based on its central role in nutrient metabolism, TOR functions as a primordial negative
regulator of autophagy in organisms from yeast to mammals (Neufeld, 2010). The best-
characterized mechanism is through inhibition of the autophagy-initiating Atg1
(homologous to ULK1 in mammals) kinase complex (Fig. 1) (Reviewed by Mizushima et
al., 2011), although TORC1 may phosphorylate other components to suppress autophagy. In
yeast, active TORC1 disrupts the Atg1 complex by phosphorylating Atg13 whereas, in
mammalian cells, mTORC1 phosphorylates ULK1 and blocks its activation under nutrient
sufficiency conditions (Kamada et al., 2000; Kim et al., 2011). Recently, mTOR was found
to play a positive role in the termination of autophagy upon prolonged starvation and to
facilitate the restoration of functional lysosomes in multiple animal species (Yu et al., 2010).
Interestingly, autophagy, which is inhibited by mTORC1, may also negatively influence cell
growth signaling. Overexpression of the autophagy initiating kinase Atg1/ULK1 represses
S6K activity in both Drosophila and mammalian cells (Lee et al., 2007; Scott et al., 2007).
These findings suggest an intricate interplay between autophagy and mTORC1.
As expected, AMPK plays a positive role in autophagy induction in response to glucose
starvation (Liang et al., 2007; Meley et al., 2006). AMPK may indirectly induce autophagy
by inhibiting mTORC1. Indeed, two recent studies uncovered a direct mechanism by AMPK
to promote autophagy (Egan et al., 2011; Kim et al., 2011). AMPK phosphorylates and
activates the autophagy essential kinase ULK1. As the major energy sensor, AMPK may
induce autophagy by regulating additional autophagic machinery downstream of the ULK1
complex.
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As the “energy factory” for the cell, mitochondrial biogenesis in the long term increase the
energy generation through oxidative catabolism. Chronic activation of AMPK by treating
rodents with either AMPK activator (Narkar et al., 2008; Winder et al., 2000) or drug
inducing energy stress (Zong et al., 2002) caused a significant increase in the expression of
mitochondrial genes and mitochondrial biogenesis in muscle. Interestingly, although mTOR
functions in anabolic pathways that are generally antagonized by AMPK, these two kinases
seem to display consistent regulation on mitochondrial biogenesis (Fig. 1), possibly due to
similar demand for energy. For example, hyperactivation of mTORC1 increases
mitochondrial DNA content and the expression of many oxidative-related genes
(Cunningham et al., 2007). In agree with this, Raptor deficiency in skeletal muscle results in
a defect in mitochondrial biogenesis and oxidative capacity (Bentzinger et al., 2008). The
regulation of mitochondrial biogenesis by AMPK and mTOR seems to converge on the
same protein, peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α), a key
nuclear cofactor for mitochondrial biogenesis and oxidative metabolism. AMPK directly
phosphorylates PGC1α and promotes the activation of its own transcription (Jager et al.,
2007), while mTOR promotes the transcriptional activity of PGC1α by enhancing its
interaction with the transcription factor yin-yang 1 (YY1) (Cunningham et al., 2007).
Lipid and nucleic acid metabolism
Another important intracellular energy source, lipid metabolism, is also tightly regulated by
AMPK. In fact, one of the best-characterized downstream targets of AMPK is the fatty acid
metabolism pathway. AMPK decreases fatty acid synthesis by phosphorylating and
inhibiting acetyl CoA carboxylase 1 (ACC1), the key regulatory enzyme in fatty acid
synthesis (Fig. 1) (Davies et al., 1992; Munday et al., 1988). In addition, AMPK also down-
regulates the expression of enzymes involved in fatty acid synthesis at the transcriptional
level, possibly through phosphorylation and inhibition of the lipogenic transcription factor
sterol regulatory element-binding protein 1C (SREBP-1C) (Li et al., 2011). Furthermore,
AMPK promotes uptake and β-oxidation of fatty acids in mitochondria. This is achieved by
AMPK-dependent phosphorylation and inhibition of ACC2, an ACC isoform responsible for
synthesis of malonyl CoA, which decreases fatty acid entry into mitochondria by inhibiting
the carnitine O-palmitoyltransferase 1 (CPT1) system (Merrill et al., 1997). Consequently,
AMPK activation results in inhibition of lipogenesis and activation of fatty acid oxidation.
Lipids are also used as building material for membranes and are in high demand for growing
cells. Lipid biosynthesis is coordinated with cell growth and is controlled by mTOR.
Inhibition of mTORC1 reduces the expression of SREBP1/2 and prevents SREBP1/2
activation by proteolytic processing, resulting in a significant decrease of lipogenic gene
expression (Fig. 1) (Duvel et al., 2010; Porstmann et al., 2008; Wang et al., 2011). A recent
study further demonstrated that mTORC1 promotes the function of SREBP through
phosphorylating Lipin-1, a phosphatidic acid phosphatase, and preventing its nuclear entry
and suppression on SREBP1/2 (Peterson et al., 2011). In addition, mTORC1 may also
regulate lipid synthesis by upregulating peroxisome proliferator-activated receptor γ
(PPARγ), a key regulator of lipid uptake and adipogenesis (Kim and Chen, 2004; Le
Bacquer et al., 2007; Zhang et al., 2009). The ability of mTORC1 to increase lipid synthesis
likely contributes to cell growth promotion.
Nucleic acids are another group of biomolecules essential for cell growth. Biosynthesis of
nucleotides shares several important characteristics with lipid biosynthesis. For example,
both use glucose as a carbon source and consume TCA cycle intermediates. In addition, they
also require reductive power in the form of NADPH. Carbon diverted from the glycolytic
flux to the pentose phosphate pathway (PPP) is used to generate ribose-5-phosphate (R5P)
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for de novo nucleotide biosynthesis (Deberardinis et al., 2008). The regulation of nucleotide
biosynthesis by metabolic status has emerged as a topic of interest, although the mechanism
is still poorly understood. A recent study demonstrated a link between mTOR signaling and
nucleotide biosynthesis, in which mTORC1 activation leads to induction of genes encoding
the enzymes of the oxidative PPP, possibly mediated by SREBP1 (Duvel et al., 2010).
HIF1α is found as another potentially important regulator of nucleotide biosynthesis.
Nonhypoxic induction of HIF1α in leukemia cells promotes the flux of glucose carbon
through PPP and is critical for leukemia cell growth and survival (Zhao et al., 2010).
Together with its function in inducing glycolytic flux, HIF1α seems to play an essential role
in directing glucose metabolism for both energy source and building blocks of nucleic acids.
It is of note that HIF1α induces nucleotide biosynthesis by promoting the flux of glucose
carbon through a nonoxidative arm of PPP (Zhao et al., 2010). In contrast to its role in
stimulating glycolytic flux, HIF1α is not the downstream mediator of mTORC1 in
promoting nucleotide biosynthesis.
Sensing metabolic intermediates and epigenetic regulation
In addition to extracellular nutrients, the cell has developed intricate mechanisms to sense
cellular metabolite concentrations in order to regulate metabolism and cellular functions
accordingly. For example, the AMP activated protein kinase (AMPK), as discussed above, is
a master cellular energy sensor that regulates a wide range of cellular activities. Moreover,
many metabolic enzymes are regulated by allosteric activation or inhibition. Most of the
allosteric regulators are often key metabolic intermediates, such as ATP, ADP, NAD, and
NADH, to provide feedback inhibition or feed forward activation. For example, AMP
activates the glycolytic enzyme phosphofructose kinase (Wegener and Krause, 2002).
Conversely, ADP inhibits the activity of PEPCK, a key regulatory enzyme in
gluconeogenesis. Therefore, glycolysis and gluconeogenesis are activated and inhibited,
respectively, when cellular AMP and ADP levels are elevated under energy stress. This type
of regulation usually affects one specific metabolic enzyme at a time and will not be
discussed here as a mechanism of global nutrient sensing. In addition, metabolic
intermediates can have a global effect by influencing processes involved in broad cellular
regulation, particularly through gene expression as discussed below.
Recent studies revealed that the Fe(II)- and α-KG-dependent dioxygenase family may play a
broad role in sensing metabolic intermediates to regulate cell growth, or even promote
tumorigenesis by altering gene expression., The PHD involved in HIFα hydroxylation is one
such example as discussed above (Fig. 2). There is convincing evidence suggesting that
PHD may be inhibited by metabolites, such as fumarate and succinate (Koivunen et al.,
2007; Selak et al., 2005), which are intermediates of the citric acid cycle. Fumarate and
succinate are structurally similar to α-KG and can function as competitive inhibitors to
suppress PHD activity when these metabolites are accumulated at high levels, and succinate
itself is a byproduct of the hydroxylation reaction (Fig. 2B). This situation is certainly
applicable to some type of cancers, which contain mutations in fumarase (FH) or succinate
dehydrogenase (SDH) (Koivunen et al., 2007; Selak et al., 2005). Cancer associated
mutations (loss of function) of FH or SDH result in abnormal accumulation of succinate or
fumarate, respectively, leading to PHD inhibition and HIFα accumulation. Tumors
harboring these mutations often have a hypoxic transcription profile. This may provide one
mechanism how mutation of these metabolic enzymes influence gene expression and
promote tumor growth.
Dioxygenase is a large family of enzymes. There are estimated to be more than 60 α-KG-
dependent dioxygenases in humans based on sequence homology of active sites (Rose et al.,
2011). The Jumonji C (JmjC) domain histone demethylases, also known as lysine
demethylase (KDM), are members of the dixoygenases and their activity depends on
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molecular oxygen and α-KG (Fig. 2B) (Mosammaparast and Shi, 2010; Tsukada et al.,
2006). Moreover, the ten-eleven translocation (TET) tumor suppressor protein, capable of
catalyzing the hydroxylation of the 5-methylcytosine leading to demethylation of DNA, is a
member of the dioxygenase family (Fig. 2B) (Tahiliani et al., 2009). It has been suggested
that activity of both the histone and DNA demethylase may be regulated by metabolic
intermediates. For example, high concentration of succinate and fumarate can inhibit the
activity of TET2 and KDM4A, a JmjC family histone demethylase (Xiao et al., 2012). These
epigenetic regulations will lead to a global alteration of gene expression and eventually
influence cellular activities, including metabolism and cell growth. Therefore, the
dioxygenase family appears to play a key role in sensing metabolic intermediates to
influence epigenetic modifications and gene expression.
Because α-KG is a common metabolic intermediate involved in multiple cellular reactions
(Fig. 2A), the concentration of α-KG may reflect cellular metabolic status. The levels of α-
KG should be determined by the rates of its production and utilization in the cell. A major
source of α-KG is from glutamine, which is first converted to glutamate and then to α-KG
by glutamate dehydrogenase (Fig. 2A). Amino acid catabolism of arginine, histidine, and
proline produces glutamate that can serve as a source for α-KG. α-KG can also be produced
by oxidation of isocitrate in the TCA cycle as well as by transamination of glutamate with
other α-ketoacid, such as pyruvate or oxaloacetate. On the other hand, α-KG can be utilized
by multiple reactions, including those involved in amino acid biosynthesis, the TCA cycle,
and production of isocitrate. The isocitrate produced serves as an important intermediate for
acetyl-CoA production and fatty acid synthesis. Furthermore, α-KG is an essential substrate
for a large number of dioxygenases as discussed above. The role of α-KG in supporting
dioxygenases may serve as a metabolic barometer to globally influence cellular physiology
and cell growth.
Altered metabolism is a hallmark of cancer (Vander Heiden et al., 2009). The metabolic
changes in cancers may be sensed by the dioxygenases that detect the level of α-KG and its
competitive inhibitory metabolites to alter histone and DNA methylation, thus affecting
gene expression. Mutations in genes encoding for several metabolic enzymes have been
found in human cancer. Eight genes, FH, SDHA, SDHB, SDHC, SDHD, SDHAF2, IDH1
and IDH2, encoding four different metabolic enzymes—FH, SDH, and isocitrate
dehydrogenase 1 and 2 (IDH1 and IDH2) are mutated, both inherently and somatically, in
human cancers (Reviewed by Oermann et al., 2012). A common feature associated with
these mutations is the accumulation of metabolites. Fumarate and succinate are elevated in
tumors with mutation of FH or SDH. The IDH mutation is particularly notable, for it
decreases α-KG and more importantly generates a new oncometabolite, 2-hydroxylglutarate
(2-HG) (Fig. 2A) (Dang et al., 2009; Zhao et al., 2009). Interestingly, 2-HG has been shown
to inhibit the activity of TET and KDM, suggesting a possible mechanism of 2-HG, hence
IDH mutation, in tumorigenesis (Xu et al., 2011). Consistent with TET as a direct target of
the oncometabolite 2-HG, mutation of the tumor suppressor TET2, is mutually exclusive
with mutation of IDH in leukemia (Figueroa et al., 2010). Moreover, the IDH mutant tumors
display a gene expression profile similar to tumors containing the TET2 mutation,
supporting both IDH and TET function in the same pathway. Furthermore, JmjC family
member KDM has been implicated in human cancer (Rotili and Mai, 2011). Together these
observations suggest a critical role for dioxygenase in sensing metabolites, hence the
metabolic status, to regulate cell growth.
It is worth noting that fast proliferating embryonic cells display metabolism properties
similar to cancer cells, such as elevated glycolysis. Epigenetic modifications and
transcription regulation are critically important in cell differentiation and reprogramming.
One may speculate that the altered metabolic status may contribute to the maintenance and
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differentiation of stem cells and progenitor cells because the effect of metabolites on the
dioxygenase-dependent epigenetic modification and altered gene expression.
Conclusion
Cell growth has to be coordinated with extracellular nutrients and intracellular metabolite
concentrations because they provide both energy and building blocks for synthesis of macro
biomolecules. The status of cellular energy and nutrients can be reflected by the activity of
AMPK and mTORC1, respectively. AMPK and mTORC1 regulate cell metabolism and
growth by phosphorylating a wide spectrum of targets, particularly those involved in protein
synthesis, mitochondrial biogenesis, glucose and lipid metabolism, and autophagy. Through
AMPK and mTOR, therefore, nutrients modulate cellular metabolic status, which is
reflected by the concentrations of key metabolic intermediates, such as α-KG. The
dioxygenase family of enzymes monitors α-KG as a substrate and other metabolites as
competitive inhibitors to control epigenetic modifications and gene expression. The
interplay among nutrients, metabolites, protein phosphorylation, and gene expression are
involved in the coordination of cell growth with extracellular and intracellular conditions.
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Nutrient sensing and metabolism pathways. AMP-activated kinase (AMPK) is activated by
energy stress and promotes catabolic pathways to produce ATP while switching off ATP-
consuming anabolic pathways. In contrast, mammalian target of rapamycin complex 1
(mTORC1) activation under nutrient-sufficiency leads to significant elevation of anabolic
processes, such as protein and lipid synthesis. Abbreviations are: GLU4, glucose transporter
type 4; CPT1, Carnitine Palmitoyltransferase-1; TAK1, TGFβ-activated kinase 1; LKB1,
liver kinase B1 (a key AMPK activator tumor suppressor); CAMKKβ, Calmodulin-
dependent protein kinase kinase β; ACC, acetyl CoA carboxylase; PFK2,
Phosphofructokinase 2; GS, glycogen synthase; HDACs, histone deacetylases; CRTC2,
CREB-regulated transcription co-activator 2; FOXO, forkhead box protein O; CREB, cAMP
response element-binding protein; ULK, UNC-51-like kinase; FIP200, 200 kDa FAK family
kinase-interacting protein; ATG, autophagy-related; PI3K, phosphoinositide 3-kinase; IRS1,
insulin receptor substrate 1; PTEN, phosphatase and tensin homologue; PDK1, 3-
phosphoinositide-dependent protein kinase 1; TSC1/2, tuberous sclerosis 1/2; Rheb, Ras
homologue enriched in brain; v-ATPase, vacuolar H+-adenosine triphosphatase; 4E-BP1,
eukaryotic initiation factor 4E-binding protein 1; S6K, ribosomal S6 kinase; Ragulator, a
protein complex responsible for lysosomal recruitment and activation of Rag GTPases;
PGC1α, peroxisome proliferator-activated receptor-γ coactivator 1α; PPARγ, peroxisome
proliferator-activated receptor-γ; SREBP, sterol regulatory element-binding protein; HIF,
Hypoxia-inducible factors. Stimulatory interactions are indicated with ↓ and inhibitory
interactions are indicated with ⊥.
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Dioxygenases in sensing metabolic intermediates and epigenetic regulation. (A) Schematics
of α-KG metabolism and TCA cycle. The mutant isocitrate dehydrogenase (IDH) (indicated
with a star) may decrease α-KG and generate a new oncometabolite 2-hydroxylglutarate (2-
HG). (B) A proposed role of dioxygenases in metabolite sensing and epigenetic
modifications. Using α-KG as a key substrate, dioxygenases is involved in HIFα
hydroxylation, DNA demethylation, and histone demethylation. All processes are inhibited
by normal metabolites, such as succinate and fumarate, as well as oncometabolite 2-HG. α-
KG, α-ketoglutarate; GDH, glutamate dehydrogenase; SDH, succinate dehydrogenase; FH,
fumarase; TET, ten-eleven translocation; KDM, lysine demethylase; PHD, prolyl
hydroxylase domain protein.
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